Distinguished in Carnitine-Acylcarnitine Translocase Deficiency

Suresh V. Vijay

Steelhouse Lane, 
Birmingham, ENG, GB 
Distinguished in Carnitine-Acylcarnitine Translocase Deficiency
Steelhouse Lane, 
Birmingham, ENG, GB 
OverviewLocationsClinical Research

Overview

Suresh Vijay practices in Birmingham, United Kingdom. Mr. Vijay is rated as a Distinguished expert by MediFind in the treatment of Carnitine-Acylcarnitine Translocase Deficiency. His top areas of expertise are Lysosomal Acid Lipase Deficiency, Wolman Disease, Cholesteryl Ester Storage Disease, Carnitine-Acylcarnitine Translocase Deficiency, and Liver Transplant.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Carnitine-Acylcarnitine Translocase Deficiency.

Gender
Male

Locations

Steelhouse Lane, Birmingham, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Arimoclomol Prospective Double-blind, Randomised, Placebo-controlled Study in Patients Diagnosed With Niemann-Pick Disease Type C
Arimoclomol Prospective Double-blind, Randomised, Placebo-controlled Study in Patients Diagnosed With Niemann-Pick Disease Type C
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Drug
Study Drug: Arimoclomol
Study Phase: Phase 2/Phase 3
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
Enrollment Status: Completed
Publish Date: January 10, 2024
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
A Multi-Center Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Enrolled in the Hunter Outcome Survey (HOS) Receiving Idursulfase Enzyme Replacement Therapy
A Multi-Center Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Enrolled in the Hunter Outcome Survey (HOS) Receiving Idursulfase Enzyme Replacement Therapy
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Biological
View 2 Less Clinical Trials

30 Total Publications

Improving sapropterin administration efficacy in PKU: Clinical practice case studies.
Improving sapropterin administration efficacy in PKU: Clinical practice case studies.
Journal: Molecular genetics and metabolism reports
Published: April 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vijay's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile